Regulus Therapeutics (RGLS) Tops Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY

6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

August 8, 2023 5:35 PM UTC

Price: $8.16 --0%

Today's EPS Names:
More

Regulus Therapeutics (NASDAQ: RGLS) reported Q2 EPS of ($0.37), $0.04 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Regulus Therapeutics (RGLS) click here.

Earnings

Earnings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!